SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biochem Pharma (BCHE)
An SI Board Since June 1996
Posts SubjectMarks Bans Symbol
783 13 0 BCHE
Emcee:  Constant Reader Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
633 Dear Todd: Regarding the CCHE spinoff (which for me at least is more of a headJDN-6/6/1999
632 I think BCHE's problem is that unlike U.S. companies, they aren't focuTodd D. Wiener-6/5/1999
631 Dear Aggie and all: Yes, I have been puzzled with BCHE shareholder value. My JDN-6/5/1999
630 Hello, all "BioChem Pharma is renowned for its pioneering discovery of aAggie-6/5/1999
629 BioChem Pharma's Antiviral Patent Portfolio - Company Holds Patents on FTC Drapeau-6/3/1999
628 Canada NewsWire BIOCHEM PHARMA ANNOUNCES SOUTH KOREAN LAUNCH OF ZEFFIX - First Drapeau-5/26/1999
627 Hepatology 1999 May;29(5):1581-6 Multicenter study of lamivudine therapy for Harold Engstrom-5/7/1999
626 AWSJ: Glaxo Prepares To Launch Marketing Blitz In China By STEPHEN D. MOORE DowJim Oravetz-5/3/1999
625 Lamivudine sales just getting underway, unless people believe that once the marOrwell-5/2/1999
624 I'm still unclear as to the purpose of the CCHE spinoff. It would have beenTodd D. Wiener-4/30/1999
623 Jim, I think what was actually under review is Biochem's decision to move Syncrude-4/30/1999
622 I'm not sure about the timing or the content of the referenced reports. RecJim Oravetz-4/30/1999
621 Jim, hello, >>Earlier in the year, several analysts wrote reports warninAggie-4/30/1999
620 From YAHOO Individual Investor: Shares of BioChem Pharma (NASDAQ:BCHE - news) Aggie-4/30/1999
619 BioChem Pharma Dn; 1Q Lamivudine Sales Lower Than Expected By MARY WEIL Dow JonJim Oravetz-4/30/1999
618 ABN Amro cut BCHE to hold from outperform. On Dow Jones News Service at 9:00AM MskiHntr-4/30/1999
617 To All, Yikes! What was that? Somebody just dumped about 600K shares, price Aggie-4/30/1999
616 Biochem Pharma: Will Hepatitis B Cure its Shares? Analyst: Eric Singer 4/16/99 Jim Oravetz-4/30/1999
615 The short interest isn't that high, but the stock is having trouble breakinTodd D. Wiener-4/30/1999
614 There have been a couple of small upticks in earnings estimates during the pastRichard Haugland-4/29/1999
613 Hello, all Say......what's with this turkey, anyway? Goods news seems to Aggie-4/29/1999
612 Anyone hearing any recent talk of takeover???jim-4/23/1999
611 From Wall Street Journal Interactive edition, what will the effect in the stockLouis XIX-4/11/1999
610 i guess thats what this medium is all about, sharing info.goodluck nrr norm roberts-3/27/1999
609 Dear Norm: Thanks for the info. I didnt know that. JDN JDN-3/25/1999
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News